Investing Profile

Chris Bischoff

InvestorVC
Managing Director at General Catalyst
Photo of Chris Bischoff, Managing Director at General Catalyst

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
General Catalyst Managing Director
$500K - $10.0M
$2.0M
42
$1.1B
CompanyStageDateRound SizeTotal Raised
Chamber Cardio
SeedMar 2024$8M
$8M
Overjet
Series CMar 2024$53M
Series BDec 2021$43M
Series AAug 2021$27M
$130M
Co-investors: Lonne Jaffe (Insight Partners), Phil Boyer (Crosslink Capital), Solomon Hailu (March Capital)
Harbor Health
Series AJan 2024$96M
$96M
Phare Health
SeedNov 2023$3M
$3M
Lottie
Series AOct 2023$20M
SeedJul 2022$7M
$28M
Co-investors: Sonali De Rycker (Accel), Ciaran O'Leary (BlueYard Capital), Jacob Haddad, Tom Blomfield, Victoria van Lennep, Alexander Ljung, Rubin Ritter, Dominic McGregor
Memora Health
Series UnknownApr 2023$30M
$81M
Co-investors: Karen Page (B Capital Group), Vineeta Agarwala (Andreessen Horowitz), Adam Grosser (UP.Partners), Brenton Fargnoli (AlleyCorp), Rich Kleiman (Thirty Five Ventures), Kevin Durant (Thirty Five Ventures), Zach Weinberg (Curie.Bio), Nat Turner (Operator Partners), Todd Cozzens (Transformation Capital), Eric Tarczynski (Contrary Capital)
Doccla
Series ASep 2022$17M
$20M
Co-investors: Cameron McLain (Giant Ventures)
Certify
Series ASep 2022$15M
$20M
Co-investors: Will Young (Trust Ventures), Bart Macdonald (bloom venture partners)